Clinical Trials
14 trialsNCT04372914 2026-02-20
Prevention of Oral DNA Damage by Black Raspberries
Milton S. Hershey Medical Center
Phase NA Completed
NCT04738643 2025-05-08
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT04308226 2024-10-09
Lung Cancer Screening Navigation for Homeless People
Massachusetts General Hospital
Phase NA Completed
NCT04250727 2024-05-01
ZYN
Yale University
Phase NA Completed
NCT04737031 2024-02-13
SPP1
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT04914000 2023-04-25
Motivating a Spectrum of Cancer Patients to Quit Smoking
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00589277 2021-08-26
Message Framing for Telephone Quitline Callers
Yale University
Phase 1/2 Completed
NCT00606502 2021-03-05
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
NCT03742154 2020-10-28
Hollings Cancer Center Varenicline Sampling Study
Medical University of South Carolina
Phase EARLY_PHASE1 Completed
NCT03482583 2020-05-22
Tobacco Use Treatment in Cancer Patients
University of Florida
Phase 4 Completed
NCT01758731 2019-09-23
Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History
University of Colorado, Denver
Phase 1 Completed
NCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01342523 2015-10-14
NCI
University of Wisconsin, Madison
Phase 4 Completed
NCT01021215 2015-04-02
Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers
National Cancer Institute (NCI)
Phase 1/2 Completed